If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Publisher: Elsevier

Volume 1, Number 3, September 2002

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Cell and cytokine profile in nasal secretions in cystic fibrosis
pp. 110-115(6)
Authors: Bergoin, C.; Gosset, P.; Lamblin, C.; Bolard, F.; Turck, D.; Tonnel, A.B.; Wallaert, B.

Favourites:Add to Favourites

Peripheral muscle strength in young males with cystic fibrosis
pp. 116-121(6)
Authors: Hussey, J.; Gormley, J.; Leen, G.; Greally, P.

Favourites:Add to Favourites

Parental fears of Pseudomonas infection and measures to prevent its acquisition
pp. 122-130(9)
Authors: Ullrich, G.; Wiedau-Gors, S.; Steinkamp, G.; Bartig, H.; Schulz, W.; Freihorst, J.

Favourites:Add to Favourites

Resting energy expenditure and lung disease in cystic fibrosis
pp. 131-136(6)
Authors: Dorlochter, L.; Roksund, O.; Helgheim, V.; Rosendahl, K.; Fluge, G.

Favourites:Add to Favourites

Validation of the SF-36 for the assessment of quality of life in adolescents and adults with cystic fibrosis
pp. 137-145(9)
Authors: Gee, L.; Abbott, J.; Conway, S.P.; Etherington, C.; Webb, A.K.

Favourites:Add to Favourites

Falsely elevated serum tobraycin levels in a patient receiving nebulised tobramycin
pp. 146-147(2)
Authors: Struthers, S.L.; Nicholson, T.; Jones, G.; Connett, G.J.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more